AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 2810163 — intervention group
Group type: EXPERIMENTAL
Intervention: Caudal analgesia (1 ml 0.2% bupivacaine/kg)
Number of subjects: 44
Study 2810163 — intervention group
Group type: COMPARATOR
Intervention: Ilioinguinal block (0.25 ml 0.5% bupivacaine/kg)
Number of subjects: 44
Study 30890109 — intervention group
Group type: EXPERIMENTAL
Intervention: Brain stem ICH
Number of subjects: 195
Study 30890109 — intervention group
Group type: COMPARATOR
Intervention: Cerebellar ICH
Number of subjects: 195
Study 28494097 — intervention group
Group type: EXPERIMENTAL
Intervention: Azathioprine 1.5-2.5 mg/kg per day with methylprednisolone 0.5 mg/kg per day
Number of subjects: 54
Study 28494097 — intervention group
Group type: COMPARATOR
Intervention: Dapsone 1.5 mg/kg per day with methylprednisolone 0.5 mg/kg per day
Number of subjects: 54
Study 25534356 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin (3000 IU)
Number of subjects: 58
Study 25534356 — intervention group
Group type: COMPARATOR
Intervention: Placebo (NaCl 0.9%)
Number of subjects: 58
Study 25148377 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg/day fluconazole for 8 days
Number of subjects: 21
Study 25148377 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 22773109 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training
Number of subjects: 1620
Study 19945929 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic walking program using heart rate monitor and pedometer for 8 weeks
Number of subjects: 40
Study 19945929 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 40
Study 17561418 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucosamine hydrochloride and chondroitin sulfate (GH/CS)
Number of subjects: 89
Study 17561418 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89
Study 16215305 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent maximal androgen blockade (IMAB)
Number of subjects: 51
Study 12130483 — intervention group
Group type: EXPERIMENTAL
Intervention: Filgrastim-mobilized peripheral blood progenitor cells
Number of subjects: 350
Study 12130483 — intervention group
Group type: COMPARATOR
Intervention: Bone marrow cells
Number of subjects: 350
Study 10428127 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-assisted arthroscopic microdiscectomy (Group 2)
Number of subjects: 60
Study 10428127 — intervention group
Group type: COMPARATOR
Intervention: Open laminotomy and discectomy (Group 1)
Number of subjects: 60
Study 7676782 — intervention group
Group type: EXPERIMENTAL
Intervention: Eltanolone 0.6 mg.kg-1 (group E1)
Number of subjects: 60
Study 7676782 — intervention group
Group type: EXPERIMENTAL
Intervention: Eltanolone 0.8 mg.kg-1 (group E2)
Number of subjects: 60
Study 7676782 — intervention group
Group type: COMPARATOR
Intervention: Thiopental 4 mg.kg-1 (group T)
Number of subjects: 60
Study 2286699 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomipramine
Number of subjects: 25
Study 2286699 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 7015131 — intervention group
Group type: EXPERIMENTAL
Intervention: Heroin
Number of subjects: 166
Study 7015131 — intervention group
Group type: COMPARATOR
Intervention: Morphine
Number of subjects: 166
Study 7015131 — intervention group
Group type: EXPERIMENTAL
Intervention: Both drugs
Number of subjects: 166
Study 31660904 — intervention group
Group type: COMPARATOR
Intervention: Intense Pulsed Light (IPL) treatment course: 3 times at 3‐week intervals
Number of subjects: 45
Study 31660904 — intervention group
Group type: COMPARATOR
Intervention: Intraductal Meibomian Gland Probing (MGP) one time
Number of subjects: 45
Study 31660904 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined MGP followed by IPL treatment course
Number of subjects: 45
Study 28437225 — intervention group
Group type: EXPERIMENTAL
Intervention: Neck collar with mild jugular vein compression
Number of subjects: 52
Study 28437225 — intervention group
Group type: COMPARATOR
Intervention: Non-collar group
Number of subjects: 52
Study 25854016 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) at shaoyang meridian points
Number of subjects: 110
Study 25854016 — intervention group
Group type: COMPARATOR
Intervention: Electroacupuncture (EA) at non-meridian points
Number of subjects: 110
Study 24073838 — intervention group
Group type: EXPERIMENTAL
Intervention: Oversewing of the staple line (Group A)
Number of subjects: 60
Study 24073838 — intervention group
Group type: COMPARATOR
Intervention: No reinforcement (Group B)
Number of subjects: 60
Study 21151016 — intervention group
Group type: EXPERIMENTAL
Intervention: Meal Replacements (MR)
Number of subjects: 113
Study 21151016 — intervention group
Group type: COMPARATOR
Intervention: Conventional Diet (CD)
Number of subjects: 113
Study 21151016 — intervention group
Group type: COMPARATOR
Intervention: All groups (MR+MR, MR+CD, CD)
Number of subjects: 113
Study 19767384 — intervention group
Group type: EXPERIMENTAL
Intervention: Medtronic MiniMed Paradigm REAL-Time system (PRT group)
Number of subjects: 132
Study 19767384 — intervention group
Group type: COMPARATOR
Intervention: Conventional insulin pump therapy (CSII group)
Number of subjects: 132
Study 19767384 — intervention group
Group type: EXPERIMENTAL
Intervention: Medtronic MiniMed Paradigm REAL-Time system (PRT group) with protocol compliance
Number of subjects: 132
Study 19767384 — intervention group
Group type: COMPARATOR
Intervention: Conventional insulin pump therapy (CSII group) with protocol compliance
Number of subjects: 132
Study 18075301 — intervention group
Group type: EXPERIMENTAL
Intervention: 1E10 anti-idiotype vaccine (1 mg of 1E10/Alum) administered via five bi-weekly injections followed by 10 doses at 28-day intervals.
Number of subjects: 71
Study 15506688 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium aluminate cement (CAC)
Number of subjects: 46
Study 15506688 — intervention group
Group type: COMPARATOR
Intervention: Resin composite (RC)
Number of subjects: 46
Study 11514816 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal manipulative therapy
Number of subjects: 30
Study 11514816 — intervention group
Group type: COMPARATOR
Intervention: Placebo (nonfunctional ultrasound application)
Number of subjects: 30
Study 9258265 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet plus resistance training
Number of subjects: 21
Study 9258265 — intervention group
Group type: COMPARATOR
Intervention: Diet alone
Number of subjects: 21
Study 7946940 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole 100 mg i.v. single dose
Number of subjects: 10
Study 2905255 — intervention group
Group type: EXPERIMENTAL
Intervention: roxatidine acetate 75 mg twice daily
Number of subjects: 308
Study 2905255 — intervention group
Group type: COMPARATOR
Intervention: ranitidine 150 mg twice daily
Number of subjects: 308
Study 28870095 — intervention group
Group type: EXPERIMENTAL
Intervention: Chining decoction (CHIN)
Number of subjects: 70
Study 28870095 — intervention group
Group type: COMPARATOR
Intervention: recombinant human epidermal growth factor (rhEGF) spray
Number of subjects: 70
Study 26916363 — intervention group
Group type: EXPERIMENTAL
Intervention: 5.1% weight loss
Number of subjects: 51
Study 26916363 — intervention group
Group type: EXPERIMENTAL
Intervention: 10.8% weight loss
Number of subjects: 51
Study 26916363 — intervention group
Group type: EXPERIMENTAL
Intervention: 16.4% weight loss
Number of subjects: 51
Study 26916363 — intervention group
Group type: COMPARATOR
Intervention: Weight maintenance
Number of subjects: 51
Study 24998106 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine as first analgesic medication
Number of subjects: 60
Study 24998106 — intervention group
Group type: COMPARATOR
Intervention: WHO analgesic ladder (non-opioids, weak opioids, strong opioids)
Number of subjects: 60
Study 22662739 — intervention group
Group type: EXPERIMENTAL
Intervention: Online education, support, and self-care promotion for caregivers of persons with dementia
Number of subjects: 0
Study 22662739 — intervention group
Group type: COMPARATOR
Intervention: Telephone options
Number of subjects: 0
Study 20538867 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone 25 mg per day
Number of subjects: 420
Study 20538867 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 420
Study 18800887 — intervention group
Group type: EXPERIMENTAL
Intervention: Basswood honey
Number of subjects: 12
Study 18800887 — intervention group
Group type: COMPARATOR
Intervention: Honey-comparable glucose-fructose solution
Number of subjects: 12
Study 18800887 — intervention group
Group type: EXPERIMENTAL
Intervention: Both solutions (honey and honey-comparable glucose-fructose solution)
Number of subjects: 12
Study 16311569 — intervention group
Group type: EXPERIMENTAL
Intervention: Teledentistry system (store and forward with photographs sent as email attachments)
Number of subjects: 327
Study 16311569 — intervention group
Group type: COMPARATOR
Intervention: Usual letter referral system (control group)
Number of subjects: 327
Study 11956541 — intervention group
Group type: EXPERIMENTAL
Intervention: Argon beam coagulation (ABC)
Number of subjects: 432
Study 11956541 — intervention group
Group type: COMPARATOR
Intervention: Electrocoagulation (EC)
Number of subjects: 432
Study 9583838 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat diet (46% fat)
Number of subjects: 103
Study 9583838 — intervention group
Group type: COMPARATOR
Intervention: Low-fat diet (24% fat)
Number of subjects: 103
Study 7624187 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental results differentiating creative thinking and creativity from psychopathological modes of response
Number of subjects: 0
Study 7624187 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 87830 — intervention group
Group type: EXPERIMENTAL
Intervention: Adsorbed vaccine
Number of subjects: 0
Study 87830 — intervention group
Group type: COMPARATOR
Intervention: Plain formol toxoid
Number of subjects: 0
Study 87830 — intervention group
Group type: EXPERIMENTAL
Intervention: Both vaccines
Number of subjects: 0
Study 31929124 — intervention group
Group type: EXPERIMENTAL
Intervention: Cenit technique
Number of subjects: 97
Study 31929124 — intervention group
Group type: COMPARATOR
Intervention: 2 x 1 technique
Number of subjects: 97
Study 30554220 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet enhanced with extra virgin olive oil and pistachios (40-42% fats of total caloric intake)
Number of subjects: 697
Study 30554220 — intervention group
Group type: COMPARATOR
Intervention: Standard-care control group (30% of total caloric intake from fats)
Number of subjects: 697
Study 30554220 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet enhanced with extra virgin olive oil and pistachios
Number of subjects: 697
Study 28346721 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic lumbopelvic stabilization (DLS) exercises
Number of subjects: 33
Study 28346721 — intervention group
Group type: COMPARATOR
Intervention: Exercises for pelvic floor muscles (PFM)
Number of subjects: 33
Study 26010794 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric training
Number of subjects: 24
Study 26010794 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic training
Number of subjects: 24
Study 26010794 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24
Study 26010794 — intervention group
Group type: EXPERIMENTAL
Intervention: Active stiffness assessment
Number of subjects: 24
Study 23547212 — intervention group
Group type: EXPERIMENTAL
Intervention: Early local joint swelling and tenderness (at least once, or for ≥ 2 consecutive visits) in the first 2 years
Number of subjects: 290
Study 23547212 — intervention group
Group type: EXPERIMENTAL
Intervention: Swelling without tenderness
Number of subjects: 290
Study 23547212 — intervention group
Group type: EXPERIMENTAL
Intervention: Persistent swelling and/or tenderness
Number of subjects: 290
Study 23547212 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline erythrocyte sedimentation rate
Number of subjects: 290
Study 23547212 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of rheumatoid factor
Number of subjects: 290
Study 23547212 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of anticitrullinated protein antibodies
Number of subjects: 290
Study 23547212 — intervention group
Group type: EXPERIMENTAL
Intervention: Large-joint damage
Number of subjects: 290
Study 21570685 — intervention group
Group type: EXPERIMENTAL
Intervention: simvastatin 40 mg + ezetimibe 10 mg (S+E)
Number of subjects: 67
Study 21570685 — intervention group
Group type: COMPARATOR
Intervention: simvastatin 40 mg (S)
Number of subjects: 67
Study 21570685 — intervention group
Group type: EXPERIMENTAL
Intervention: ezetimibe 10 mg (E)
Number of subjects: 67
Study 19352163 — intervention group
Group type: EXPERIMENTAL
Intervention: Flumazenil (0.5 mg)
Number of subjects: 60
Study 19352163 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 60
Study 16765796 — intervention group
Group type: EXPERIMENTAL
Intervention: Vancomycin (20 microg/mL) and gentamicin (8 microg/mL) in the infusion fluid
Number of subjects: 41
Study 16765796 — intervention group
Group type: COMPARATOR
Intervention: No antibiotics in the infusion fluid (control group)
Number of subjects: 41
Study 16765796 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with increased macular thickness on OCT
Number of subjects: 41
Study 16765796 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with no change in macular thickness on OCT
Number of subjects: 41
Study 15499292 — intervention group
Group type: EXPERIMENTAL
Intervention: MR techniques
Number of subjects: 30
Study 15499292 — intervention group
Group type: EXPERIMENTAL
Intervention: Radionuclide studies (nor‐cholesterol)
Number of subjects: 30
Study 15499292 — intervention group
Group type: EXPERIMENTAL
Intervention: Radionuclide studies (MIBG)
Number of subjects: 30
Study 15499292 — intervention group
Group type: EXPERIMENTAL
Intervention: Radionuclide studies (FDG)
Number of subjects: 30
Study 11878735 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron 4 mg
Number of subjects: 40
Study 11878735 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline (placebo)
Number of subjects: 40
Study 11367660 — intervention group
Group type: EXPERIMENTAL
Intervention: Bushen Tiaogan Lianru Recipe (BTLR)
Number of subjects: 72
Study 11367660 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine
Number of subjects: 72
Study 11367660 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Control group)
Number of subjects: 72
Study 8151047 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomipramine
Number of subjects: 84
Study 8151047 — intervention group
Group type: EXPERIMENTAL
Intervention: Desipramine
Number of subjects: 84
Study 8151047 — intervention group
Group type: COMPARATOR
Intervention: Clomipramine or Desipramine
Number of subjects: 84
Study 3596865 — intervention group
Group type: EXPERIMENTAL
Intervention: Voltaren 25, Ciba‐Geigy
Number of subjects: 8
Study 3596865 — intervention group
Group type: EXPERIMENTAL
Intervention: Anfenax 25, Istituto Biochimico Italiano
Number of subjects: 8
Study 3596865 — intervention group
Group type: COMPARATOR
Intervention: Ciba‐Geigy preparation
Number of subjects: 8
Study 3596865 — intervention group
Group type: COMPARATOR
Intervention: Istituto Biochimico Italiano preparation
Number of subjects: 8
Study 29288510 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychopharmacotherapy with nursing interventions for anxiety (Nursing Interventions Classification)
Number of subjects: 60
Study 29288510 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (psychopharmacotherapy only)
Number of subjects: 60
Study 26592506 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone
Number of subjects: 4873
Study 26592506 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4873
Study 24620855 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral therapy with Repaglinide
Number of subjects: 74
Study 24620855 — intervention group
Group type: COMPARATOR
Intervention: Insulin therapy
Number of subjects: 74
Study 22700378 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved household water infrastructure
Number of subjects: 0
Study 21518046 — intervention group
Group type: EXPERIMENTAL
Intervention: RBC transfusion in MOF patients
Number of subjects: 29
Study 21518046 — intervention group
Group type: EXPERIMENTAL
Intervention: RBC transfusion in patients developing MOF
Number of subjects: 29
Study 21518046 — intervention group
Group type: COMPARATOR
Intervention: No RBC transfusion
Number of subjects: 29
Study 18499566 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalirudin alone
Number of subjects: 3602
Study 18499566 — intervention group
Group type: COMPARATOR
Intervention: Heparin plus glycoprotein IIb/IIIa inhibitors
Number of subjects: 3602
Study 17024986 — intervention group
Group type: EXPERIMENTAL
Intervention: Advertisements in major Montreal newspapers
Number of subjects: 2001
Study 17024986 — intervention group
Group type: EXPERIMENTAL
Intervention: Placement of ads in senior newspapers
Number of subjects: 2001
Study 12704000 — intervention group
Group type: EXPERIMENTAL
Intervention: COAPC regimen combined with whole-brain radiotherapy (WBRT)
Number of subjects: 45
Study 10948073 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 99
Study 10948073 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight management combining aerobic exercise with a behavioral weight loss program
Number of subjects: 99
Study 8833718 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric-only dynamic constant external resistance (DCER) training of the leg extensor muscles (3-5 sets of 6 repetitions at 80% of the eccentric one-repetition maximum load) for eight weeks
Number of subjects: 17
Study 8833718 — intervention group
Group type: COMPARATOR
Intervention: Eccentric-only dynamic constant external resistance (DCER) training of the leg extensor muscles
Number of subjects: 17
Study 1423946 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined lower limbs and upper limbs (LL+UL) exercise
Number of subjects: 24
Study 1423946 — intervention group
Group type: COMPARATOR
Intervention: Lower limbs (LL) exercise alone
Number of subjects: 24
Study 1423946 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined LL+UL exercise
Number of subjects: 24
Study 3532786 — intervention group
Group type: EXPERIMENTAL
Intervention: Auranofin (3 mg twice daily)
Number of subjects: 303
Study 31935136 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-mobilization plus CrossFit training
Number of subjects: 70
Study 31935136 — intervention group
Group type: EXPERIMENTAL
Intervention: CrossFit training alone
Number of subjects: 70
Study 31935136 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 70
Study 30077184 — intervention group
Group type: EXPERIMENTAL
Intervention: Early treatment with ibuprofen (COXi) between 24 and 72 hours postnatal age
Number of subjects: 0
Study 30077184 — intervention group
Group type: COMPARATOR
Intervention: Expectative management (no intervention intended to close a PDA)
Number of subjects: 0
Study 30077184 — intervention group
Group type: EXPERIMENTAL
Intervention: Early treatment with ibuprofen (COXi)
Number of subjects: 0
Study 30077184 — intervention group
Group type: COMPARATOR
Intervention: Expectative management
Number of subjects: 0
Study 27093514 — intervention group
Group type: EXPERIMENTAL
Intervention: Early Feedback Group (EFG)
Number of subjects: 18
Study 27093514 — intervention group
Group type: COMPARATOR
Intervention: Late Feedback Group (LFG)
Number of subjects: 18
Study 24549548 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram (10 mg per day titrated to 30 mg per day over 9 weeks)
Number of subjects: 186
Study 24549548 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram
Number of subjects: 186
Study 24549548 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 186
Study 22954510 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone (50mg)
Number of subjects: 40
Study 22954510 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 20886789 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) combined with acupoint sticking therapy (AST)
Number of subjects: 90
Study 20886789 — intervention group
Group type: COMPARATOR
Intervention: Western medication (Mesalazine)
Number of subjects: 90
Study 18426893 — intervention group
Group type: EXPERIMENTAL
Intervention: Levofloxacin
Number of subjects: 32
Study 18426893 — intervention group
Group type: COMPARATOR
Intervention: Ceftriaxone
Number of subjects: 32
Study 19951520 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal inhaled corticosteroid (ICS) through a spacer with mask (budesonide inhaler 400 microg/d)
Number of subjects: 72
Study 19951520 — intervention group
Group type: COMPARATOR
Intervention: Orally inhaled budesonide dry powder (400 microg/d) plus nasal spray of budesonide aquae (256 microg/d)
Number of subjects: 72
Study 15364229 — intervention group
Group type: EXPERIMENTAL
Intervention: Loteprednol etabonate ophthalmic suspension, 0.5%, 4 times a day for 4 weeks
Number of subjects: 64
Study 15364229 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (placebo)
Number of subjects: 64
Study 11457700 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified phenol chemical peels with varying concentrations of phenol and croton oil
Number of subjects: 16
Study 11457700 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized application technique
Number of subjects: 16
Study 9190324 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol 300mg/day (oral)
Number of subjects: 60
Study 9190324 — intervention group
Group type: COMPARATOR
Intervention: Buprenorphine 0.6mg/day (sublingual)
Number of subjects: 60
Study 7955906 — intervention group
Group type: EXPERIMENTAL
Intervention: L-arginine infusion (30 g, 30 min)
Number of subjects: 10
Study 7955906 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 3117236 — intervention group
Group type: EXPERIMENTAL
Intervention: somatrem (methionyl growth hormone)
Number of subjects: 26
Study 3117236 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 26
Study 30683140 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing intervention to reduce re-hospitalization through patient activation
Number of subjects: 385
Study 30683140 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants who agreed to the intervention
Number of subjects: 385
Study 29871327 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior approach parotid gland region resection preserving retinal ganglion and parotid fascia
Number of subjects: 112